Oscar Health, Inc. reports news on its healthcare technology business, which uses a full-stack platform to offer Individual & Family health plans, ICHRA solutions, +Oscar technology services and the Lucie Health Marketplace. Company updates commonly cover quarterly financial results, medical loss ratio and expense metrics, guidance, membership trends and product expansion in the individual health insurance market.
Oscar Health announcements also include marketplace and plan launches, broker and employer-facing healthcare shopping tools, technology features, capital-structure activity and board governance changes. The company’s recurring news themes connect its insurance products, member experience and healthcare technology services to developments in ACA exchange markets and consumer-directed coverage.
Oscar Health reported significant growth in Q2 2022, with Direct and Assumed Policy Premiums rising to $1.7 billion, a 101% increase year-over-year. Premiums earned also grew by 88% to $995 million. Membership surged to 1,036,720, an 84% increase YoY. Despite these gains, the company posted a net loss of $112 million, up 39 million YoY, alongside an Adjusted EBITDA loss of $76 million. Key ratios improved, with Medical Loss Ratio at 82.2% and Administrative Expense Ratio at 19.5%. Oscar reaffirms its 2022 outlook for continued growth and improved profitability.
Oscar Health, Inc. (NYSE: OSCR) will announce its second-quarter 2022 financial results on August 11, 2022, after market close. A conference call for management to review the results will take place at 5:00 PM ET. Interested parties can join via a live call at (888) 550-4423 or access the webcast link. Oscar, founded in 2012, emphasizes a technology-driven approach to health insurance, serving over one million members as of March 31, 2022.
Oscar Health, Inc. (NYSE: OSCR) has launched its Next Best Actions engine, enhancing member communication through targeted messaging. Integrated with +Oscar’s Campaign Builder, it applies behavioral science to improve campaign conversion rates. The initiative has achieved a 48% engagement rate with members, driven a 20% rise in overall engagement, and increased campaign volume by 40%. This innovation aims to reduce information overload among members, facilitating better healthcare decisions and outcomes.
Oscar Health, Inc. (NYSE: OSCR) announced on June 8, 2022, that its Board of Directors approved the grant of 992,382 restricted stock unit awards to 29 non-executive employees. This grant is intended to incentivize these new hires under Oscar’s 2022 Employment Inducement Award Plan. The awards will generally vest quarterly over three years, contingent on continued employment. Oscar Health, founded in 2012 and headquartered in New York City, aims to enhance healthcare access through its technology-driven health insurance model.
Oscar Health reported a strong first quarter for 2022, with membership reaching 1,073,595, a 98% year-over-year increase. Total direct and assumed policy premiums surged to $1.7 billion, up 104% YoY, while premiums earned rose 159% to $955 million. Although the Medical Loss Ratio increased to 77.4%, the net loss decreased by $12 million to $77 million. Adjusted EBITDA loss was $37 million. Oscar reaffirmed its 2022 outlook and continues to focus on profitability, market growth, and product acceleration.
Oscar Health, Inc. (NYSE: OSCR) has announced that its Co-Founder & CEO, Mario Schlosser, will present at the Bank of America Securities 2022 Healthcare Conference on Thursday, May 12, 2022, at 8:40 AM PT (11:40 AM ET). The presentation will be available via a virtual webcast, and the link can be found in the press release. Oscar has gained the trust of over one million members and focuses on making healthcare accessible and affordable through its full stack technology platform.
Oscar Health, Inc. (NYSE: OSCR) announced on April 13, 2022, that its Board's Compensation Committee approved the grant of 311,192 Class A restricted stock units to 21 new non-executive employees. This is part of Oscar's 2022 Employment Inducement Award Plan, aimed at attracting talent. The awards vest quarterly over three years, contingent upon continued employment. Oscar, founded in 2012, operates as a technology-driven health insurance provider with over one million members as of January 2022, offering various insurance plans while focusing on a member-first philosophy.
Oscar Health, Inc. (NYSE: OSCR) is scheduled to release its Q1 2022 financial results post-market on May 10, 2022. A conference call will follow at 5:00 PM ET to discuss the results, accessible via phone or webcast. Oscar, established in 2012, is a tech-driven health insurance company serving over one million members as of January 2022. The company focuses on accessibility and affordability in healthcare, offering various insurance plans, including Individual, Family, Small Group, and Medicare Advantage plans.
Oscar Health (NYSE: OSCR) will host a virtual investor day on March 25, 2022, at 9:00 AM ET. Management will discuss the company's 2021 performance, vision, strategic plans, and guidance for fiscal 2022. Oscar, established in 2012, leverages a technology platform to provide insurance services, serving over one million members as of January 2022. For further details, investors can access the investor relations website for more information on this event.
Oscar Health, Inc. (NYSE: OSCR) announced that Co-Founder & CEO Mario Schlosser will present at the Cowen 42nd Annual Health Care Conference on March 9, 2022, at approximately 9:50 AM ET via a virtual webcast. This event will highlight Oscar's innovative approach to health insurance, focusing on technology and member service. As of January 2022, Oscar has earned the trust of over one million members. The event will be archived on Oscar's investor relations website.